NovaBay Pharmaceuticals, Inc. (NBY)

NovaBay Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	2	1	4	17	29	18
Market Cap Growth	-8.93%	-63.21%	-78.61%	-41.88%	63.09%	35.23%
Enterprise Value	3	1	0	10	18	15
PE Ratio	-	-0.08	-0.22	-2.58	-2.64	-1.70
PS Ratio	0.16	0.09	0.25	1.66	2.93	2.71
PB Ratio	14.66	0.40	0.34	1.66	2.36	18.35
P/FCF Ratio	-0.77	-0.32	-0.54	-1.83	-6.13	-2.25
P/OCF Ratio	-0.77	-0.32	-0.54	-1.84	-6.17	-2.25
EV/Sales Ratio	0.21	0.07	0.02	0.98	1.78	2.27
EV/EBITDA Ratio	-0.34	-0.11	-0.03	-1.75	-1.61	-1.56
EV/EBIT Ratio	-0.34	-0.11	-0.03	-1.71	-1.60	-1.55
EV/FCF Ratio	-0.91	-0.25	-0.04	-1.08	-3.72	-1.88
Debt / Equity Ratio	15.14	0.79	0.19	0.05	0.04	4.16
Debt / EBITDA Ratio	-0.22	-0.28	-0.20	-0.10	-0.05	-0.42
Debt / FCF Ratio	-0.59	-0.63	-0.30	-0.06	-0.11	-0.51
Quick Ratio	0.65	0.84	1.72	2.66	4.61	1.41
Current Ratio	0.92	1.67	2.66	3.83	5.03	1.65
Asset Turnover	1.32	1.12	0.68	0.64	0.72	0.58
Return on Equity (ROE)	-389.10%	-240.20%	-112.50%	-62.90%	-164.60%	-626.70%
Return on Assets (ROA)	-171.60%	-126.70%	-76.40%	-41.10%	-80.20%	-92.40%
Return on Capital (ROIC)	-287.77%	-128.16%	-114.47%	-82.65%	-50.12%	-187.29%
Earnings Yield	-790.94%	-1253.55%	-449.21%	-38.75%	-37.91%	-58.73%
FCF Yield	-174.80%	-311.57%	-186.87%	-54.62%	-16.30%	-44.51%
Buyback Yield / Dilution	-1112.38%	-161.80%	-29.11%	-24.43%	-62.08%	-26.87%
Total Shareholder Return	-1112.38%	-161.80%	-29.11%	-24.43%	-62.08%	-26.87%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).